2024 HFSA AHFTC Board Certification Review

2024 HFSA AHFTC Board Certification Review - Attendee Access

COURSE INFORMATION

This product is the complimentary OnDemand access exclusively for registered attendees of the live program.

The HFSA AHFTC Board Certification Review 2024 (Live Access) features the pre-recorded presentations and recorded live sessions from the course, providing in-depth insights into advanced heart failure and transplant cardiology.

Designed to support preparation for the ABIM Advanced Heart Failure and Transplant Cardiology Board Certification and Maintenance of Certification Exams, this resource includes a curated Question Bank and reading list. Attendees can also complete course evaluations to claim credits.

INTENDED AUDIENCE

The 2024 HFSA AHFTC Board Certification Review is designed for physicians who are preparing to take the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination or the Maintenance of Certification Assessment Examination, or heart failure specialists seeking an in-depth review in heart failure.

LEARNING OBJECTIVES

For the Certification Examination in Advanced Heart Failure and Transplant Cardiology:

This course is designed to:

Review testable content and the focus of the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination.
Identify gaps in knowledge about advanced heart failure and transplant cardiology.
Explain how to best focus study efforts on filling identified knowledge gaps.
Provide practice for the certification examination with ABIM-style multiple-choice test questions.

For Clinical Practice:

Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure.
Discuss the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms.
Assess and treat patients with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
Apply guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices.
Incorporate appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, valvular heart disease, pregnancy-associated disease, and cardiorenal syndrome.
Manage comorbidities in patients with chronic heart failure, including sleep-disordered breathing, anemia, and diabetes.
Implement strategies for effective disease management of patients with advanced heart failure, including referral for mechanical circulatory support, heart transplant, or palliative care.
Manage immunosuppressive therapies and common complications of heart transplant, including rejection, allograft vasculopathy, and immunosuppression-associated conditions.
Utilize mechanical support devices, both temporary and durable.
Manage common complications of mechanical circulatory support.

PRE-MEETING ONDEMAND PRESENTATIONS

Heart Failure Epidemiology and Risk Factors - Clyde Yancy
Pathophysiology 1: Cellular and Energetic Considerations - Daniel Burkhoff
Pathophysiology 2: Hemodynamic, Structural and Neurohormonal Considerations - Daniel Burkhoff
Diagnosis and Clinical Assessment - Mark Drazner
Cardio-Oncology for the HF Boards - Bonnie Ky
Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards - Jon Lomasney
Statistics for the HF Board - Brian Claggett
Hemodynamics in HF I - James Fang
Diabetes and COPD - Maria Rosa Costanzo
RV Failure and TR Management - Barry Borlaug
Management of Comorbidities in Heart Failure - Sleep Disorders - Maria Rosa Costanzo

2024 HFSA AHFTC BOARD CERTIFICATION REVIEW

Access to 2024 HFSA AHFTC Board Certification Review OnDemand presentations will be available 2 weeks after the conclusion of the live course.

Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions) - Akshay Desai
Hemodynamics in HF II - James Fang
Optimal Medical Therapy for HFrEF 1 - Mark Drazner
Optimal Medical Therapy for HFrEF 2 - Mark Drazner
Cardio Renal Failure Interactions in Heart Failure - Wendy McCallum
Assessment of Functional Capacity including cardiopulmonary exercise testing - Gregory Lewis
HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (For the Boards) - Sanjiv Shah
Management of Comorbidities in Heart Failure: Iron Deficiency/Anemia - Gregory Lewis
Pulmonary Hypertension - Classification and Initial Evaluation - Jonathan Rich
Pulmonary Hypertension – Treatment - Jonathan Rich
Specific Etiologies of HF 1: HCM - Jane Wilcox
Specific Etiologies of HF 2: Other Inherited HF syndromes - Jane Wilcox
Specific Etiologies of HF 3: Infiltrative Disorders and Restrictive CMP - Sanjiv Shah
Specific Etiologies of HF 4: Myocarditis and Inflammatory Cardiomyopathies - Maria Rosa Costanzo
Management of the Hospitalized HF Patient - Maria Rosa Costanzo
Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies - Nancy Sweitzer
Immunology: The Basics, PRA, Sensitization, Crossmatch - Sean Pinney
Rejection: Cellular and Antibody Mediated - Sean Pinney
Heart Transplant, Clinical Outcomes and Complications - Michelle Kittleson
Managing Immunosuppression and Drugs - Michelle Kittleson
Pregnancy in HF - Kathryn Lindley
Cardiogenic Shock Management - Nancy Sweitzer
MCS 1: Durable MCS Devices and Outcomes - Joseph Rogers
MCS 2: Temporary Support Devices and ECMO for the Boards - Manreet Kanwar
MCS 3: Management of complications of MCS - Manreet Kanwar
MCS 4: Interactive Shock and Device Management - Daniel Burkhoff, Manreet Kanwar, Joseph Rogers, Nancy Sweitzer
Adult Congenital Heart Disease for the HF Specialist - Eric Krieger
Management of Left Sided Valvular Heart Disease in Heart Failure - Jane Wilcox
Management of Common Arrhythmias 1 – Atrial Fibrillation and Flutter - Roderick Tung
Management of Common Arrhythmias 2 – Ventricular Arrhythmia - Roderick Tung
Device Therapy in Heart Failure I - Sudden Death Prevention - Christine Albert
Device Therapy in Heart Failure II - CRT - Christine Albert

RELATED RESOURCES

View complete program information.

IMPORTANT DATES

Live Event Dates: July 12-14, 2024

Summary


Availability:	Expires on Jul 15, 2025


Cost:	FREE


Credit Offered:	25.5 CME Credits 25.5 MOC Points


Contains:	13 Pre-recorded+ 30 Live (Total of 43 courses)

Create Account

Recommended

Heart Failure: Diagnostic Testing and Advanced Therapies

No Credit

FREE